Alan Cass1, Joan Cunningham, Paul Snelling, Zhiqiang Wang, Wendy Hoy. 1. Menzies School of Health Research, Cooperative Research Centre for Aboriginal and Tropical Health, Casuarina, Northern Territory, Australia. alancass@menzies.edu.au
Abstract
OBJECTIVE: To assess Indigenous Australians' access to renal transplantation, compared with non-Indigenous Australians. To examine whether disparities are due to a lower rate of acceptance onto the waiting list and/or a lower rate of moving from the list to transplantation. DESIGN: National cohort study using data from the Australian and New Zealand Dialysis and Transplant Registry. We included all end-stage renal disease (ESRD) patients under 65 years of age who started treatment in Australia between January 1993 and December 1998. We used survival analysis to examine the time from commencement of renal replacement therapy (RRT) to transplantation. We measured time from commencement of RRT to acceptance onto the waiting list (stage 1), and time from acceptance onto the waiting list to transplantation (stage 2). The main outcome measures were (1) acceptance onto the waiting list and (2) receipt of a transplant, before 31 March 2000. RESULTS: Indigenous patients had a lower transplantation rate (adjusted Indigenous: non-Indigenous rate ratio 0.32, 95% CI 0.25-0.40). They had both a lower rate of acceptance onto the waiting list (adjusted rate ratio 0.50, 95% CI 0.44-0.57) and a lower rate of moving from the list to transplantation (adjusted rate ratio 0.50, 95% CI 0.38-0.65). The disparities were not explained by differences in age, sex, co-morbidities or cause of renal disease. CONCLUSIONS: Indigenous Australians face barriers to acceptance onto the waiting list and to moving from the list to transplantation. Further research to identify the causes could facilitate strategies to improve equity in transplantation.
OBJECTIVE: To assess Indigenous Australians' access to renal transplantation, compared with non-Indigenous Australians. To examine whether disparities are due to a lower rate of acceptance onto the waiting list and/or a lower rate of moving from the list to transplantation. DESIGN: National cohort study using data from the Australian and New Zealand Dialysis and Transplant Registry. We included all end-stage renal disease (ESRD) patients under 65 years of age who started treatment in Australia between January 1993 and December 1998. We used survival analysis to examine the time from commencement of renal replacement therapy (RRT) to transplantation. We measured time from commencement of RRT to acceptance onto the waiting list (stage 1), and time from acceptance onto the waiting list to transplantation (stage 2). The main outcome measures were (1) acceptance onto the waiting list and (2) receipt of a transplant, before 31 March 2000. RESULTS: Indigenous patients had a lower transplantation rate (adjusted Indigenous: non-Indigenous rate ratio 0.32, 95% CI 0.25-0.40). They had both a lower rate of acceptance onto the waiting list (adjusted rate ratio 0.50, 95% CI 0.44-0.57) and a lower rate of moving from the list to transplantation (adjusted rate ratio 0.50, 95% CI 0.38-0.65). The disparities were not explained by differences in age, sex, co-morbidities or cause of renal disease. CONCLUSIONS: Indigenous Australians face barriers to acceptance onto the waiting list and to moving from the list to transplantation. Further research to identify the causes could facilitate strategies to improve equity in transplantation.
Authors: Susan M Samuel; Bethany J Foster; Marcello A Tonelli; Alberto Nettel-Aguirre; Andrea Soo; R Todd Alexander; Lynden Crowshoe; Brenda R Hemmelgarn Journal: CMAJ Date: 2011-05-24 Impact factor: 8.262
Authors: Susan M Samuel; Bethany J Foster; Brenda R Hemmelgarn; Alberto Nettel-Aguirre; Lynden Crowshoe; R Todd Alexander; Andrea Soo; Marcello A Tonelli Journal: CMAJ Date: 2012-08-27 Impact factor: 8.262
Authors: Germaine Wong; Kirsten Howard; Jeremy R Chapman; Steven Chadban; Nicholas Cross; Allison Tong; Angela C Webster; Jonathan C Craig Journal: PLoS One Date: 2012-01-18 Impact factor: 3.240
Authors: Dana H Z Robinson; Christina P C Borba; Nancy J Thompson; Jennie P Perryman; Kimberly R Jacob Arriola Journal: Prog Transplant Date: 2009-09 Impact factor: 1.065
Authors: Jeannie Devitt; Alan Cass; Joan Cunningham; Cilla Preece; Kate Anderson; Paul Snelling Journal: BMC Health Serv Res Date: 2008-02-04 Impact factor: 2.655